Wei‐Pang Chung

Independent Researcher

0000-0001-8485-270X

Publications

1,993

Citations

H-Index

i10-Index

20.17

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

80 total

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial PDF

Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung, Seock‐Ah Im, William Jacot et al. - The Lancet, 2022

Cited by 603 OpenAlex

Research Topics

HER2/EGFR in Cancer Research (17) Advanced Breast Cancer Therapies (16) Breast Cancer Treatment Studies (15) Cancer Treatment and Pharmacology (15) Advanced Radiotherapy Techniques (13)

Affiliations

Pohang University of Science and Technology

KR 2003 - 2003

Korea University

KR 2015 - 2015

Christie's

GB 2017 - 2017

Kyung Hee University

KR 2015 - 2012

Nanomed (Brazil)

BR 2021 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Wei‐Pang Chung

Publication & Citation Trends

Publications

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial PDF

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back